Company page

Adma Biologics Inc

Adma Biologics Inc, trading under the ticker ADMA, is a public company based in the United States with a market capitalization of approximately $1.93 billion. The company focuses on developing and commercializing specialty biologics for the treatment of infectious diseases and immune deficiencies. Adma is committed to advancing healthcare solutions through its innovative products and research initiatives.